Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
Supplies of a Critical Bladder Cancer Drug are Dwindling Bob Field, a 72-year-old New York banking executive, received a call from his urologist’s office canceling his next appointment. According to…
Continue Reading
Supplies of a Critical Bladder Cancer Drug are Dwindling
According to a recent article published by the University of California San Francisco, Pelizaeus-Merzbacher disease (PMD) is a rare neurological disease affecting young boys. PMD fatalities may occur before the child…
Continue Reading
Found: Pelizaeus-Merzbacher Disease, the Cause, and a Potential Cure
Physician and investigator John Wood, MD, Ph.D. of Childrens Hospital of Los Angeles specializes in studying the challenges facing SCD patients. He has currently focused his attention on how oxygen delivery…
Continue Reading
Studies Reveal How Blood Flow and Oxygen Delivery Are Affected by Sickle Cell Disease (SCD)
According to a recent article in SMA News Today, risdiplam (formerly RG7916) is in ongoing studies of patients with spinal muscular atrophy (SMA). The drug is an investigational medicine developed by Genentech…
Continue Reading
Clinical Trials Show Promising Results for Risdiplam in Treatment of Spinal Muscular Atrophy Types 1, 2, and 3
Waukesha Wisconsin Police Captain Dan Baumann recently held a news conference that was described in an article published in Scientific American. Captain Baumann said that parents of a teenage boy showed…
Continue Reading
ICYMI: Doctors Searching for the Cause of a Deadly Lung Disease Warn: Do Not Vape
FierceBiotech recently reported that Helixmith Co., based in Korea and previously known as ViroMed, coordinated a Phase 3 clinical trial involving five hundred diabetic peripheral neuropathy (DPN) patients. The…
Continue Reading
The Phase 3 Trial in Diabetic Peripheral Neuropathy May Have Failed Due to a Critical Mistake
Pamela Smith, age 67, had run out of options when her melanoma metastasized and became inoperable. According to a recent article in MedicalXpress, in January 2014, Pamela joined the…
Continue Reading
Metastatic Melanoma was Untreatable but Two Drugs Have Changed the Landscape
The Providence Journal recently published an article by Brittany Ricci, a student at Brown University’s Alpert Medical School, detailing her year-long struggle to receive the treatment her doctor had prescribed…
Continue Reading
Step Therapy Supposedly Minimizes Risk, but for Brittany it Caused Severe Complications
A new treatment was recently tested for blastic plasmacytoid dendritic cell neoplasm (BPDCN). A recent article in MD Anderson News points out that in the U.S., five hundred to…
Continue Reading
This Treatment for BPDCN is Having an Impact on the Lives of Patients
Richard Engel’s son Henry, age 4, has been diagnosed with Rett syndrome, a thus far incurable genetic neurological disease. Engel is chief foreign war correspondent at NBC and has…
Continue Reading
Chief Foreign War Correspondent at NBC News Gives Account of His 4-Year-Old Son With Rett Syndrome
A molecular biologist, Dr. Daria Julkowska, coordinates an international consortium in Paris that is largely funded through the 28-member European Union (EU). According to a report published in the Charcot-Marie-Tooth…
Continue Reading
A New European Consortium Dedicated to Finding and Treating Rare Diseases
Alzheimer’s disease (AD) is a neurodegenerative disease and the major cause of impaired memory affecting the older population. Reported cases are rapidly increasing. So far, clinical trials have failed…
Continue Reading
Waging An All-Out War on Alzheimer’s Disease
The accelerated approval granted by the FDA for the Duchenne muscular dystrophy drug eteplirsen, developed by Sarepta Therapeutics, was granted only after internal disagreements and protests had been resolved.…
Continue Reading
FDA Approval Was Granted For a Duchenne Muscular Dystrophy Drug Amid Internal Disagreements
Fierce Biotech recently focused on a report by The BMJ, a British science journal, on the validity of clinical trials which are critical to decision making by patients and…
Continue Reading
British Science Journal Authors Voice Concerns Over Low Standards Supporting Cancer Drugs
Glen Sauber successfully overcame testicular cancer and was symptom-free-- until three years later when he began to experience neurological symptoms. According to a recent article in the San Francisco Chronicle,…
Continue Reading
Antibodies Destroyed the Cancer– But Then They Attacked the Brain
The city of Jacobina, Brazil in the Bahia region was selected as the ideal area for a study designed to control disease-bearing mosquitoes. A recent report in the Science…
Continue Reading
450,000 Genetically Modified Mosquitoes Were Released Every Week for Two Years
Diffuse large B-cell lymphoma (DLBCL) is a common type of non-Hodgkins lymphoma. World Pharma News recently reported that the FDA approved the first chemoimmunotherapy, Polivy, for DLBCL in combination with…
Continue Reading
FDA Approves a Combination of Drugs for Diffuse Large B-cell Lymphoma
Why would someone compare genetic editing to weapons of mass destruction? Perhaps one answer can be found in the automobile. The family automobile was certainly not designed as a weapon…
Continue Reading
Why Would Anyone Try to Compare Genetic Engineering to Weapons of Mass Destruction?
According to a recent article in MedicalXpress, the newest discovery in the search to reduce the risk of AD was through the work of researchers led by Dr. Jaehong Suh,…
Continue Reading
Alzheimer’s Disease: A Long Journey and Another Step Forward
The fountain of youth may actually be in a cocktail of drugs that were part of a new study on aging. A recent article in Longevity’s Science Research announced…
Continue Reading
A New Study Reveals That Our Biological Age Can Be Reversed
According to a recent article in The Scientist, Northwestern Medicine’s successful autoimmune and immunotherapy program is winding down and will be closed by the end of the year. The program,…
Continue Reading
The Sudden Closure of Northwestern University’s Stem Cell Therapy Clinic Raises Questions That Remain Unanswered
Pharmacogenomics plays an important role in predicting whether patients will benefit from certain medications or if the medication will cause serious side effects. The process involves the way in…
Continue Reading
Patients in Mayo Clinic’s RIGHT Study Carried One or More Genetic Variants That May Affect Their Response to Medication
According to a recent article in Archive Today, an international band of amateur biologists, or "biohackers" announced that they intend to eventually market a knock-off of Glybera, a one…
Continue Reading
Biohacking: A Small Group of Amateur Biologists Are Hoping to Market Their Knockoff of a One Million Dollar Gene Therapy
A recent article in Northwestern's University Health reported that although the survival rate for cancer patients has vastly improved over the past twenty years, the deaths due to metastatic cancer…
Continue Reading
A New Approach to Halting Metastatic Cancer
Clustered Regularly Interspaced Short Palindromic Repeats is more commonly known as CRISPR. As reported recently in Science News, the CRISPR/Cas9 “molecular scissors” is slated to make its highly anticipated debut…
Continue Reading
CRISPR Gene Editing Promises to Cure 10,000 diseases. Now in Its First Human Clinical Trial. Will it Eventually Deliver?